This masterclass is now at capacity, if you wish to be added to the waitlist please contact the events team on firstname.lastname@example.org
NICE and the ABPI invite you to the third event in the NICE/DSU/ABPI Masterclass Programme for 2021 - Optimising NICE submissions in oncology.
Monday 22 November 2021 - 9:30 to Friday 26 November 2021 - 12:30
This masterclass will consider via presentations and interactive workshops:
- Key issues in oncology appraisals
- Extrapolation of survival data
- Handling treatment crossover in oncology trials
- A view from the Appraisal Committee
The sessions will highlight key methodological and practical issues involved in these appraisals and will set out the available methods for handling them. Recent developments will also be highlighted.
The masterclass is specifically designed for staff in pharmaceutical companies who prepare submissions, the consultancies that support them, and members of the academic groups who review submissions.
This masterclass is best suited to those with an understanding of health economics, who are familiar with NICE requirements and those who want to hear the NICE perspective first-hand from world-leading experts in NICE appraisals.
Speakers and moderators for the sessions include:
- Professor Paul Tappenden, ScHARR
- Dr Kate Ren, ScHARR
- Dr Nick Latimer, ScHARR
- Dr Mark Rutherford, University of Leicester
- Professor John Cairns, London School of Hygiene and Tropical Medicine
The format will be virtual over three morning sessions on Monday 22, Wednesday 24 and Friday 26 November 2021.
You will need to attend ALL sessions to complete the Masterclass.
Places on this Masterclass are limited and offered on a first come first served basis.